Page last updated: 2024-11-02

phenoxybenzamine and Adenocarcinoma, Basal Cell

phenoxybenzamine has been researched along with Adenocarcinoma, Basal Cell in 3 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Liang, P1
Li, J1
Chen, J1
Lu, J2
Hao, Z1
Shi, J1
Chang, Q1
Zeng, Z1
Chung, FH1
Chiang, YR1
Tseng, AL1
Sung, YC1
Huang, MC1
Ma, N1
Lee, HC1
Paris, H1
Taouis, M1
Galitzky, J1

Other Studies

3 other studies available for phenoxybenzamine and Adenocarcinoma, Basal Cell

ArticleYear
Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs.
    Scientific reports, 2022, 05-03, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Carrier Proteins; Histocompatibility Antigens Class I; Humans; Lung; Lung Neoplasms;

2022
Functional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Adenocarcinoma; Algorithms; Colorectal Neoplasms; Drug Repositioning; Epistasis, Genetic; Ethacrynic

2014
In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29.
    Molecular pharmacology, 1987, Volume: 32, Issue:5

    Topics: Adenocarcinoma; Adenylyl Cyclases; Adrenergic alpha-Antagonists; Animals; Cell Line; Cell Membrane;

1987